National Cancer Institute Cohort Consortium
Studies
49
The main objectives of NCi are:
1. Foster communication among investigators leading cohort studies of cancer.
2. Promote collaborative research projects for topics not easily addressed in a single study.
3. Identify common challenges in cohort research and search for solutions.
Visit NCI - Cohort Consortium
Investigators | Contacts |
---|---|
|
|
General Information
- Year created
- 2001
- Types of cohorts
-
- Population cohort
- Patient/disease cohort
- Clinical trial
- Region
- Asia, Australia, Europe, North America, Canada, New Zeland.
- Setting
- International
- Funding
- NCI has funded investigator-initiated projects within the Cohort Consortium through competitive grant mechanisms, but all Cohort Consortium projects are subject to the same review process as other applications.
- Criteria of cohort's to be included
- The Cohort Consortium includes cohorts with a minimum of 10,000 study participants, in which cancer occurrence is accurately assessed, and has available some risk factor data; OR those with a minimum of 2,000 study participants to study cancer-related outcomes among those diagnosed with cancer. All studies must commit to scientific collaboration by being willing to contribute data for scientific research and consider participating in pooling studies.
- Health topic
-
- Environmental health
- Occupational health
- Social environment
- Nutritional health
- Cancer
- General epidemiology
- Genetics
- Genomics
- Other -omics
Participants
Number of participants
- Total
- 7,000,000
Age range of the samples
- Minimum age
- 0
- Maximum age
- 100
Methodology for harmonization and integration
- Strategy of harmonization
- Ex-post
- Data processing methods
-
- NA
- Type of infrastructure
- Data are in different locations
- Integrative data analysis
-
- Meta-analyses
- Pooled analyses
- Other : https://sci-hub.tw/10.1158/1055-9965.epi-18-0182 More updated information can be obtained requesting access to CMR https://cmr.nci.nih.gov/
- Software
-
- NA
- Supplementary information
- https://www.ncbi.nlm.nih.gov/pubmed/25217961 To facilitate data sharing and data harmonization the NCI has funded the Cancer Epidemiology Descriptive Cohort Database (CEDCD) (https://cedcd.nci.nih.gov/), and the Cohort Metadata Repository (CMR) (https://cmr.nci.nih.gov/), which details past harmonization efforts.
Number of cohorts
- Total
- 66
- With harmonized data
- 20
- Will more cohorts be harmonized?
Access
- Availability of metadata
- Under request
- Availability of individual data
- Under request
Individual Studies
Acronym | Name | Study design | Participants | Countries |
---|---|---|---|---|
AHS | Agricultural Health Study (AHS)private and commercial applicators-USA | Population cohort | 89,655 | |
AHS-2 | Adventist Health Study-2 | Population cohort | 96,000 | |
ATBC | Alpha-Tocopherol, BetaCarotene Cancer Prevention Study | Clinical trial cohort | 29,133 | |
Atlantic PATH | Atlantic Partnership for Tomorrow's Health | Population cohort | 34,000 | |
ATP | Alberta's Tomorrow Project | Population cohort | 55,000 | |
BCDDP follow-up study | Breast Cancer Detection Demonstration Project Follow-up Study | Population cohort | 64,182 | |
BCFR | Breast Cancer Family Registry Cohort | Population cohort | 377,776 | |
BCGP | BC Generations Project (British Columbia) | Population cohort | 30,000 | |
BCSC | Breast Cancer Surveillance Consortium | Population cohort | 2,900,000 | |
Breakthrough Generations Study | Breakthrough Generations Study | Population cohort | 113,000 | |
BWHS | Black Women's Health Study | Population cohort | 59,000 | |
CaG | CARTaGENE | Population cohort | 43,000 | |
Canadian Study of Diet, Lifestyle, and Health | Canadian Study of Diet, Lifestyle, and Health | Population cohort | 73,909 | |
CanPath | CanPath – the Canadian Partnership for Tomorrow’s Health | Population cohort | 331,359 | |
CARET | Carotene and Retinol Efficacy Trial | Clinical trial cohort | 18,341 | |
CCFRC | Colon Cancer Family Registry Cohort | Population cohort | ||
CLUE I | Campaign against Cancer and Stroke Study (CLUE I) | Clinical trial cohort | 25,802 | |
CLUE II | Campaign against Cancer and Heart Disease Study (CLUE II) | Clinical trial cohort | 32,898 | |
CPS-II | The American Cancer Society Cancer Prevention Study II | Population cohort | 181,000 | |
CPS II Nutrition | CPS II Nutrition Cohort | Population cohort | 184,194 | |
CTS | California Teachers Study | Population cohort | 133,479 | |
EPIC | European Prospective Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle | Patients' cohort | 522,000 | |
ESMaestras | Mexican Teachers' Cohort (Estudio de Salud de las Maestras or ESMaestras) | 117,474 | ||
GS:SFHS | Generation Scotland: Scottish Family Health Study | Population cohort | 23,960 | |
HPFS | Health Professionals Follow-up Study | Population cohort | 51,529 | |
IWHS | Iowa Women's Health Study | Population cohort | 41,836 | |
Mano a Mano Cohort | Mexican American (Mano a Mano) Cohort | Population cohort | 26,672 | |
Millennium Cohort Study | Millennium Cohort Study | Population cohort | 77,058 | |
MMHS | Mayo Mammography Health Study | Other | 19,924 | |
NHS-II | Nurses' Health Study II | Population cohort | 116,430 | |
NIT | Nutrition Intervention Trials — Linxian | Clinical trial cohort | 32,887 | |
NLCS | Netherlands Cohort Study | Other | 120,852 | |
NSHDS - MA | Northern Sweden Health and Disease Study - The Mammography Screening Project | Population cohort | 28,800 | |
NSHDS - MO | Northern Sweden Health and Disease Study - The Northen Sweden Monica Project | Population cohort | 11,800 | |
NYU Women's Health Study | NYU Women's Health Study | Case-control | 14,274 | |
OHS | Ontario Health Study | Population cohort | 228,611 | |
PCPT | Prostate Cancer Prevention Trial | Clinical trial cohort | 18,882 | |
PHS-I | Physicians' Health Study I | Clinical trial cohort | 22,071 | |
PHS-II | Physicians' Health Study II | Clinical trial cohort | 14,641 | |
PLCO | Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial | Clinical trial | 155,000 | |
PONS | The Polish-Norwegian Study | Population cohort | 13,172 | |
SCCS | Southern Community Cohort Study | Population cohort | 85,000 | |
SELECT | Selenium and Vitamin E Cancer Prevention Trial | Clinical trial cohort | 34,887 | |
Sister study | Sister study | Population cohort | 50,884 | |
SNMC | Swedish National March Cohort | Population cohort | 43,880 | |
The Janus Serum Biobank | The Janus Serum Biobank | Population cohort | 316,951 | |
USRT | US Radiologic Technologists Cohort | Population cohort | 146,022 | |
VITAL | VITamins And Lifestyle Cohort Study | Population cohort | 77,738 | |
WHS | Women's Health Study | Clinical trial cohort | 39,876 |